Very excited to see this in print! Such promising outcomes for immune cold #sarcomas with Botensilimab Plus Balstilimab https://t.co/U679Y5jlJi @Agenus_Bio@CUCancerCenter
Most excited to see our study presenting the mechanism driving ~50% of osteosarcomas (LTA #chromothripsis) out in @CellCellPress! How does the final version differ from the preprint? https://t.co/ZFT444jwdL Buckle up!! -tons of new exciting results ahead! 👇👇
It has been a very hectic but productive 2024. More exciting things for the Huang Lab in the horizon for 2025 😎
For now, flying back to Singapore for a much needed break.
See you all in the New Year!
It's a wrap! The joint #Sarcomalabsretreat of @sandro_pasquali@HuangLabICR & our lab hosted at @IstTumori Milan concludes after two action-packed days of scientific exchange, deepening existing collabs & friendships, & forging new ones. Many thanks to everyone who contributed to this significant and super-fun meeting! #ultrararesarcoma #diseasemodeling #tumorheterogeneity
The final countdown until #CTOS2024 meeting!
4 days full of great science and networking with #sarcoma experts - researchers, clinicians & patient advocates from around the world!
If you can't join on-site, follow our social media and interact with colleagues using #CTOSTweeTOS
Part of Day 3 #ANZSAASM2024, we heard from international guest speakers Nathalie Gaspar and @HuangLabICR, followed by Natacha Omer’s insights on empowering the immune system against sarcoma. We also heard from Sarcoma Research Grant winners Ian Parish and Minh Son To.
‼️Coming up 🔜 @ctosociety Webinar on “Dedifferentiated Liposarcoma”- the 2024 #sarcoma of the year! Please join us for an in-depth overview of the state-of-the-art of DDLPS diagnostics, biology, and clinical management on October 10!
Register here👇
https://t.co/calRPfl1iA